SCHEMBL8287983

SCHEMBL8287983

Cc1cc2c(c(Oc3ccccc3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.39
GAA P10253 4/20 0.39
MAPK1 P28482 4/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 6/20 0.38
CYP1A2 P05177 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 2/20 0.37
CYP2C19 P33261 2/20 0.37
GPR119 Q8TDV5 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
MEN1 O00255 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286424 0.89 MAT2A (0.41) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8287979 0.87 PDE11A (0.37) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286141 0.86 PDE11A (0.39) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286426 0.86 PDE11A (0.39) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL5872108 0.84 GAA (0.44) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286140 0.83 PDE11A (0.37) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286457 0.83 LMNA (0.38) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8287944 0.83 GAA (0.43) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL5872270 0.83 PDE11A (0.44) PDE11AGAAMAPK1HPGDALDH1A1
SCHEMBL8286080 0.83 PDE11A (0.39) PDE11AGAAMAPK1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed